CHROMADEX CORPORATION
(NASDAQ: CDXC)

Chromadex Corporation is a provider of research and quality-control products and services to the natural products industry. The Company is a natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its business model that utilizes its wholly owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as phytochemicals), chemistry and analytical testing services, and product regulatory and safety consulting. The Company provides science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. Through its subsidiaries Chromadex Analytics, Inc. and Spherix Consulting, Inc., the Company performs chemistry-based analytical services and offers scientific and regulatory consulting, respectively.

3.690

-0.100 (-2.64%)
Range - - -   (-%)
Open -
Previous Close 3.790
Bid Price 1.490
Bid Volume 8
Ask Price 1.500
Ask Volume 9
Volume 308,964
Value -
Remark
Delayed prices. Updated at 20 Apr 2024 03:59.
Data powered by
View All Events

About CHROMADEX CORPORATION

Chromadex Corporation is a provider of research and quality-control products and services to the natural products industry. The Company is a natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its business model that utilizes its wholly owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as phytochemicals), chemistry and analytical testing services, and product regulatory and safety consulting. The Company provides science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. Through its subsidiaries Chromadex Analytics, Inc. and Spherix Consulting, Inc., the Company performs chemistry-based analytical services and offers scientific and regulatory consulting, respectively.

Loading Chart...

Please login to view stock data and analysis